Organizer: German Cancer Consortium Partner Site München
Registration necessary: yes
Physicians and scientists of the partner site München will discuss their latest translational research at the 4th Munich Cancer Retreat. To strengthen the relationship to industry, this year’s key note lecture will be given by the head of Roche Pharma Research & Early Development: Dr. John C. Reed.
Young DKTK scientists will have the opportunity to present their work in selected highlight talks. Best Talk as well as the Best Poster will be provided with a travel award to a european conference.
Further information is provided in the agenda of the 4th Munich Cancer Retreat.